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Epithelial differentiationV) L1 and L2 capsid protein expression is restricted to the granular layer of
infected, stratiﬁed epithelia and is regulated at least partly at post-transcriptional levels. For HPV16, a 79 nt
late regulatory element (LRE) is involved in this control. Using W12 cells as a model for HPV16-infected
differentiating cervical epithelial cells we show that HuR, a key cellular protein that controls mRNA stability,
binds the LRE most efﬁciently in nuclear and cytoplasmic extracts of differentiated cells. Further, HuR binds
the 3′ U-rich portion of the LRE directly in vitro. Overexpression of HuR in undifferentiated W12 cells results
in an increase in L1 mRNA and protein levels while siRNA knock-down of HuR in differentiated W12 cells
depletes L1 expression. In differentiated cervical epithelial cells HuR may bind and stabilise L1 mRNAs aiding
translation of L1 protein.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman papillomaviruses (HPVs) infect epithelial cells causing
benign lesion or warts, which in some rare cases can progress to
malignancy. HPVs can be classiﬁed according to whether they infect
cutaneous or mucosal epithelia and whether such infection poses a
“low” or “high risk” of tumour formation. The most important subset
medically are the anogenital infective mucosal “high risk” HPVs types
(e.g. HPV16, 18, 31, 33, 45) that cause lesions, particularly on the cervix
that, upon persistent infection, may progress to cancer. HPV16 is the
most prevalent “high risk” anogenital type being found in around 60%
of cervical lesions (zur Hausen, 2002).
HPV16 has a circular double stranded 7.9 kb DNA genome that
exists in the infected cell nucleus as multiple episomal copies. The
genome can be divided into an early coding region, encoding proteins
E1, E2, E1^E4, E5, E6 and E7, and a late coding region containing the L1
and L2 open reading frames that encode the capsid proteins. The early
and late regions are separated by the long control region (LCR) that
contains at its 3′ end, replication and transcription control elements
and at its 5′ end, the late 3′ untranslated region (Longworth andlate regulatory element; UTR,
-rich element; EMSA, electro-
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(Milligan et al., 2007).
The papillomavirus life cycle is intimately linked to epithelial
differentiation. The virus infects the dividing cells of the basal layer
and the virus genome can persist in this layer (Longworth and
Laimins, 2004). Differentiation of virus-infected basal layer cells
results in a productive infection. Viral genome ampliﬁcation occurs in
the spinous epithelial layer but production of the virus capsid proteins
is restricted to cells of the granular layer (Peh et al., 2002). Despite this,
virus late transcripts can be detected in lower epithelial layers (Stoler
et al., 1989, 1992; Beyer-Finkler et al., 1990). However, at least for
HPV16, these RNAs are unprocessed (Milligan et al., 2007) and
probably targeted for nuclear degradation. Factors expressed in the
differentiated epithelial host cells must induce appropriate expression
of the capsid proteins at a post-transcriptional level.
Viral RNA elements that bind cellular proteins have been
proposed to be involved in post-transcriptional regulation of capsid
protein expression for a number of papillomaviruses. Indeed, such
elements may be widespread among the papillomaviruses (Zhao et
al., 2007). Late 3′ UTR regulatory elements have been identiﬁed for
BPV-1 (Furth and Baker, 1991; Furth et al., 1994) and HPV-1
(Sokolowski et al., 1999) that regulate polyadenylation (Gunderson
et al., 1997) and translation (Wiklund et al., 2002) respectively.
Several elements have been identiﬁed for HPV16. All appear to
repress gene expression in HeLa cells. One is present in the 5′ end
and another at the 3′ end of the L2 open reading frame. Both these
elements have resisted precise delineation but they may regulate
mRNA stability and translation (Öberg et al., 2003). Indeed, they bind
hnRNP K and poly(rC)-binding proteins 1 and 2, two proteins known
143S.A. Cumming et al. / Virology 383 (2009) 142–149to regulate RNA stability and translation (Collier et al., 1998). Another
important region is located in the ﬁrst 514 nucleotides of the L1 open
reading frame (Collier et al., 2002). The dominant L1 element is
within the ﬁrst 129 nucleotides. There is evidence that this element
acts as an exonic sequence silencer (ESS) by binding the splicing
regulator hnRNP A1 to repress use of the 3′ splice site at the 5′ end
of the L1 open reading frame (Zhao et al., 2004). Finally, the 79 nt
HPV16 late regulatory element (LRE), which spans 27 nts at the 3′
end of the L1 open reading frame and extends 52 nts into the late 3′
UTR (Fig. 1) has a 5′ portion containing four weak 5′ splice sites that
binds a U1 snRNP-like complex and a 3′ portion that is GU-rich
(Cumming et al., 2003). In the nucleus, the 3′ portion binds the
splicing factor U2AF (Dietrich-Goetz et al., 1997) and this may recruit
the SR protein, SF2/ASF giving rise to formation of an early splicing-
like complex (McPhillips et al., 2004). There is no detectable splicing
of late transcripts within the 3′ UTR so this complex may be involved
in regulating RNA processing and stability of the RNAs (McPhillips et
al., 2004). The element may also bind CUGBP to regulate post-
transcriptional repression (Goraczniak and Gunderson, 2008). Pre-Fig. 1. HuR binds the HPV16 LRE most efﬁciently in differentiated W12 cell extracts. (A)
The LRE nucleotide sequence. Diamonds, 4 weak 5′ splice sites (Cumming et al. 2003);
underlined sequence, the 3′ U-rich region. The vertical line indicates the arbitrary
division of the 5′ and 3′ portions of the LRE. The L1 stop codon is in bold type. (B) EMSA
with [32P]-labelled in vitro-transcribed LRE RNA and nuclear (NE) and cytoplasmic (CE)
extracts from undifferentiated and differentiated W12 cells. In tracks 3, 5, 8, and 10 the
reaction mix was pre-incubated with HuR antibody 16A5 that causes complex
depletion. The probe is indicated with an arrow. The arrowhead indicates probe
resistant to denaturation at 70 °C. Stars indicate bands depleted in the presence of anti-
HuR antibody. (C) Western blots demonstrating fractionation (U2AF is a nuclear
protein) and differentiation (involucrin is a cytoplasmic protein expressed in
differentiated keratinocytes) of W12 cells and abundance of HuR (antibody 16A5) in
the various fractions. CE, cytoplasmic extract; NE, nuclear extract, UW12, undiffer-
entiated W12 cell extracts; DW12, differentiated W12 cell extracts.viously we demonstrated that the HPV16 LRE could also bind HuR
(Koffa et al., 2000). HuR is an RNA-binding protein that binds U- or
AU-rich elements (AREs). It is a member of the ubiquitous Hu/ELAV
protein family whose members regulate mRNA stability and
translation and is predominantly nuclear but can shuttle between
the nucleus and cytoplasm (Keene, 1999).
All previous HPV16 RNA/protein binding studies were in HeLa cell
extracts. Although HeLa cells are cervical epithelial cells they are
highly transformed (they express high levels of the HPV18 oncopro-
teins E6 and E7) and they cannot differentiate to cells that will support
the HPV life cycle. HeLa cells may not provide an appropriate
background to investigate the role of cellular proteins in regulation
of the HPV life cycle. In contrast, W12 cells (Stanley et al., 1989) are
immortalised but not transformed, differentiation-competent HPV16
genome-containing cervical epithelial cells. These cells can support
the HPV16 life cycle in monolayer and organotypic raft culture
(Milligan et al., 2007). Using thismodel system, we show that HuR/LRE
complex formation is most efﬁcient in the nucleus and cytoplasm of
differentiated W12 cells. Further, the 3′ U-rich portion of the element
binds puriﬁed HuR directly with high afﬁnity. Finally, transient
transfection of undifferentiated W12 cells with an expression
construct for HuR results in production of stable L1 mRNA and
production of L1 protein. Conversely, siRNA knock-down of HuR
expression in differentiated W12 cells results in abrogation of
expression of L1 protein. This indicates that HuR may contribute to
regulation of L1 protein production in an epithelial differentiation
stage-speciﬁc manner.
Results
HuR binds the HPV16 late regulatory element (LRE) in a cervical
epithelial differentiation-dependent manner
Binding of HuR to the LRE was investigated previously by our
group in HeLa cell nuclear extracts (Koffa et al., 2000). HeLa cells are
highly transformed (they express high levels of the HPV18 E6 and E7
oncoproteins) and have lost the capacity to differentiate so they are
unable to support the HPV life cycle. Moreover, recently HuR has
been demonstrated to be overexpressed in many tumours and
cancer cell lines (López de Silanes et al., 2005) such as HeLa cells. In
order to investigate HuR/LRE binding during epithelial differentiation
of nontransformed epithelial cells that better mimic the biochemical
environment of the cells HPV16 infects we used extracts from
undifferentiated and differentiated W12 cervical epithelial cells. Fig.
1B shows an electrophoretic mobility shift assay (EMSA) demon-
strating that few protein complexes were formed on the LRE in
undifferentiated W12 nuclear extracts (Fig. 1B, tracks 2 and 3). In
track 1 which shows probe alone, the band of reduced mobility is
due to secondary structure formation (Cumming et al., 2003) that is
resistant to heat denaturation. The bands of similar mobility in tracks
containing either nuclear or cytoplasmic extract may be a mix of
undenatured probe and retarded denatured probe. There is little
difference in the abundance and mobility of this band in the various
tracks. However, a signiﬁcant increase in binding of a high molecular
weight complex was observed when undifferentiated W12 cytoplas-
mic extracts were used (track 4). This conﬁrms what we found
previously with HeLa cytoplasmic extracts (Koffa et al., 2000).
Depletion of this complex (starred) was observed when the reaction
mix contained anti-HuR antibody 16A5 (Fig. 1B track 5). In contrast,
in differentiated W12 cells, there was clear formation of a high
molecular weight complex in both nuclear (track 7) and cytoplasmic
(track 9) extracts, and the largest amount of complex formed with
cytoplasmic extract. Indeed this complex had retarded mobility
compared to the complex observed with nuclear extract and so may
have a different composition. These complexes were signiﬁcantly
depleted when the binding reactions were carried out in the
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1C shows that nuclear and cytoplasmic fractions from the undiffer-
entiated and differentiated W12 cells were signiﬁcantly enriched in
proteins speciﬁc to each compartment. U2AF65, a nuclear protein,
was found largely in the nuclear fraction and involucrin, a
cytoplasmic ﬁlament protein, was found mostly in the cytoplasm.
Levels of involucrin, a marker of differentiated keratinocytes,
increased in the differentiated W12 cell cytoplasmic fraction as
expected. HuR levels did not change signiﬁcantly upon differentia-
tion and HuR was found mainly in the nuclear fraction, as expected
for a shuttling protein.
To examine HuR cellular and tissue distribution W12 cells were
grown on organotypic raft culture and raft tissues cross sections were
subject to immunostaining using anti-HuR antibody 19F12. Fig. 2
shows that the distribution of HuR throughout the W12 epithelium
was similar to the splicing factor U2AF65 but may be more abundant
overall especially in differentiated epithelial cells. However, while
U2AF65 was found to be mainly nuclear as expected HuR could be
detected in both the nucleus and the cytoplasm. No antibody controls
showed no brown staining (data not shown). This indicates a
signiﬁcant capacity for HuR shuttling in fully differentiation-compe-
tent W12 cells. The western blot in Fig. 1C does not show a very
signiﬁcant amount of HuR in the cytoplasm of undifferentiated and
differentiated W12 cells. However it is difﬁcult to equate staining
intensity from immunohistochemistry to steady state levels of protein
in cells detected by western blotting and the levels of HuR in the
densely-stained nuclei relative to the cytoplasm of the cells in Fig. 2B
may be high.Fig. 2. HuR is present in the nucleus and cytoplasm of differentiating W12 cells.
Immunostaining of 4 μm parafﬁn-embedded sections of organotypic raft cultures of
W12 cells. (A) Staining with antibody MC3 against U2AF65, a nuclear RNA processing
factor. (B) Staining with antibody 16A5 against HuR. Slides were counterstained with
hematoxylin.HuR binds the 3′ portion of the LRE directly
The 3′ portion of the HPV16 LRE contains a class III AU-rich
element (ARE) so we investigated whether it bound HuR directly.
GST–HuR was expressed in bacteria, puriﬁed then incubated with
radiolabelled full length LRE probe (Fig. 1A) in an electrophoretic gel
mobility shift assay (EMSA) (Fig. 3A). The LRE probe has the
capacity to form heat-resistant secondary structure so the probe
alone track (Fig. 3A, track 1) shows a main band representing
denatured probe and a less intense lower mobility band represent-
ing non-denatured probe. Increasing concentrations of GST–HuR
caused increased formation of LRE RNA/protein complexes (efﬁcient
binding was observed with 260 pM GST–HuR; track 3) while GST
alone did not bind the LRE (track 5). As noted for Fig. 1B, the
smallest LRE-HuR complex may have a similar mobility to the
nondenatured LRE probe that was not complexed with protein (note
the increased abundance of the starred band). Binding was speciﬁc
because nonspeciﬁc competitor, pBluescript polylinker RNA, did not
interrupt complex formation when incubated with the probe at 4
and 8-fold molar excess (tracks 6 and 7). Cold competitor LRE RNA
was able to compete efﬁciently the binding of HuR to the LRE
(tracks 8–10).
EMSA and UV crosslinking studies were used to determine which
portion of the LRE binds HuR. GST–HuR/RNA complexes were formed
when radiolabelled full length LRE and 3′ LRE probes were used (Fig.
3B tracks 2 and 8) but not when a 5′ LRE probe was used (Fig. 3B
track 5). An antisense LRE probe did not bind GST–HuR indicating
binding was speciﬁc for sense LRE RNA (Fig. 3B track 11). Addition of
HuR antibody 19F12 caused a supershift of the complexes formed
(tracks 3 and 9) conﬁrming that these were due to HuR binding. This
is different to the depletion of HuR complexes observed in Fig. 1B
where antibody 16A5 was used. These monoclonal antibodies
recognise different epitopes and this likely accounts for the
difference in response in probing RNA/protein interactions. Fig. 3C
shows the results of a UV crosslinking experiment conﬁrming that
GST–HuR binds the 3′ U-rich portion of the LRE (track 3) rather than
the 5′ portion (track 2). Fig. 3D shows a competition UV crosslinking
experiment. 32P-labelled LRE RNA was incubated with GST–HuR in
the presence of no cold probe (tracks 1 and 2), or in the presence of
cold 3′ LRE probe or cold 5′ LRE probe. Cold 3′ LRE probe competed
efﬁciently with the 32P-labelled full length LRE RNA for binding HuR.
There was some competition for binding of HuR using cold 5′ LRE
probe but a signiﬁcant amount of LRE RNA was still complexed to
GST–HuR. There is a short U-rich region within the 5′ LRE probe that
may bind HuR inefﬁciently leading to some inefﬁcient competition in
UV crosslinking. Experiments were performed in duplicate and
duplicate tracks are shown. Site directed mutagenesis studies,
changing 5 nucleotides at a time, across the LRE sequence, showed
no depletion in binding of a band at around 40 kDa that we
identiﬁed as HuR in UV cross linking studies (data not shown). This
indicates that HuR may require a large region within the 3′ LRE (30
nts in length) for most efﬁcient binding. HuR has been shown to
bind cooperatively to ARE RNAs of at least 18 nucleotides in length
(Fialcowitz-White et al., 2007). Oligomerisation of HuR on the LRE
template can be observed in Fig. 3A tracks 3 and 4.
Overexpression of HuR in undifferentiated W12 cells induces expression
of L1 protein
To determine whether HuR has any regulatory activity via LRE
binding on stability of LRE-containing RNAs, HeLa cells were
transfected with pcDNA3.1, as a vector control or a mammalian
expression vector for HuR, pcDNA3HuR and with luciferase reporter
gene constructs containing the HPV16 late 3′ UTR with or without
the LRE and reporter gene expression assayed. No signiﬁcant change
in levels of luciferase was observed upon HuR expression (data not
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signiﬁcant capacity to bind the LRE in HeLa cell cytoplasmic extracts
where it may have its effects on stability (data not shown). As HuR
is clearly able to bind the element in W12 nuclear and cytoplasmic
extracts we tested HuR control of endogenous L1 expression in
these cells. In undifferentiated W12 cells, LRE-containing RNAs are
not exported from the nucleus so L1 protein is not produced (Koffa
et al., 2000; Milligan et al., 2007). We tested whether over-
expression of HuR in undifferentiated W12 cells could induce
expression of L1 protein. Undifferentiated W12 cells were trans-
fected with pcDNA3HuR or with the vector construct with no insert,
pcDNA3.1. 16 h following transfection half of the cells were
differentiated by suspension culture in methylcellulose for 48 h.
The remaining cells were kept at low density in F-medium with low
concentrations of calcium to inhibit differentiation. RNA and protein
was isolated from the undifferentiated and differentiated W12 cells
and northern and western blotting performed. Figs. 4A and B tracks
1 show that L1 mRNA and L1 protein respectively was not detected
in undifferentiated W12 cells transfected with the control vector,pcDNA3.1. However, in cells transfected with pcDNA3HuR (tracks 2)
signiﬁcant levels of L1 mRNA and L1 protein could be detected. For
L1 protein this was around 5-fold over background upon quantiﬁca-
tion with respect to levels of GAPDH (Fig. 4C). A smear representing
L1-containg RNAs was observed in Fig. 4A, track2 because the probe
hybridises to the central portion of thirteen L1-containing, poly-
cistronic mRNAs (Milligan et al., 2007). In differentiated W12 cells
L1 mRNA and protein was detected in both the vector and
pcDNA3HuR-transfected cells as expected and little signiﬁcant
increase was observed in cells overexpressing HuR (data not
shown). HuR overexpression caused a similar level of increase in
HuR protein concentrations in both cell populations (data not
shown). This indicates that HuR may have an involvement in
regulation of L1 expression and perhaps other LRE-containing virus
late mRNAs.
siRNA depletion of HuR in differentiated W12 cells results in reduced
levels of L1 protein
Next HuR levels in W12 cells were depleted by treatment with a
pool of HuR siRNAs. Undifferentiated W12 cells were transfected with
control scrambled siRNAs or HuR siRNAs. 16 h after transfection the
cells were differentiated by growth in methylcellulose for 48 h. The
level of knock down of the protein was around 50%. Greater levels of
knock down gave poor yields of transfected cells. This may be
because HuR is known to be required for cell signalling during
differentiation and has a broad antiapoptotic function (Abdelmohsen
et al., 2007). L1 mRNAwas detected by semi-quantitative RT-PCR (Fig.
4D). GAPDH and L1 mRNAs were simultaneously ampliﬁed from
cDNAs reverse transcribed from cells transfected with control
scrambled siRNA (tracks 1 and 2) and test HuR siRNAs (tracks 3
and 4). Reverse transcriptase was omitted from the cDNA synthesis
step (tracks 1 and 3) as a control for DNA contamination. Less L1
mRNA was present in differentiated W12 cells transfected with HuR
siRNAs (track 4), than cells transfected with control scrambled siRNAs
and similarly differentiated (track 2). L1 protein was detected by
western blotting of lysates of W12 cells transfected with the control
siRNAs or the HuR siRNAs followed by differentiation in methylcel-
lulose (Fig. 4E). In accordance with the mRNA data, there were
reduced levels of L1 protein in differentiated W12 cells transfected
with the HuR siRNAs (Fig. 4E track 2) compared to cells transfected
with control siRNAs (track 1). L1 mRNA and protein wereFig. 3. GST–HuR binds the 3′ portion of the LRE with high afﬁnity. (A) Speciﬁc binding of
GST–HuR to [32P]-labelled in vitro-transcribed full length LRE RNA. Track 1, no protein;
track 2,130 pMGST–HuR (40 ng); track 3, 260 pMGST–HuR (80 ng); track 4, 520 pMGST
HuR (160 ng); track 5GSTalone. Tracks 6 and 7 EMSA reaction as in track 3 butwith 4 and
8-fold molar excess of cold pBluescript polylinker RNA (65 nts), a nonspeciﬁc
competitor; tracks 8–10 EMSA reaction as in track 3 but with 1, 2 and 4-fold molar
excess cold LRE RNA as a speciﬁc competitor. LRE RNA probe runs as a fully denatured
RNA and a band with retarded mobility due to incomplete denaturation. GST–HuR/RNA
complexes are indicated by a line to the left of the autoradiograph. A line to the right
hand side indicates probe. A possible GST–HuR complex thatmigrateswith undenatured
probe is indicated with an asterisk. (B) EMSA with [32P]-labelled in vitro-transcribed
LRE-derived RNAs showing that GST–HuR (50 ng) can form a complex speciﬁcally with
the 3′ U-rich region of HPV16 LRE RNA. GST–HuR/RNA complexes are indicated by a line
to the left of the autoradiograph. Radiolabelled free probes are indicated with a line to
the right hand side of the autoradiograph. LRE, full length LRE probe; 5′ LRE, nts 7127–
7174 of the HPV16 genome; 3′ LRE, nts 7175–7206 of the HPV16 genome;αsense LRE, in
vitro transcribed full length antisense LRE sequence. Tracks 3, 6, 9 and 12 showsupershift
of HuR/LRE RNA complexes using antibody 19F12. (C) [32P]-labelled in vitro-transcribed
LRE-derived RNAs UV crosslinked to GST–HuR protein (50 ng). LRE, full length LRE RNA
probe; 5′, RNAprobe transcribed from the 5′ portion of the LRE sequence, nts 7127–7174;
3′ RNA probe transcribed from the 5′ portion of the LRE sequence, nts 7175–7206; αs,
antisense RNA probe transcribed from full length LRE. (D) [32P]-labelled in vitro-
transcribed LRE-derived RNAs UV crosslinked to GST–HuR protein (50 ng) in the
presence of no cold speciﬁc competitor (tracks 1 and 2), 3′ LRE RNAprobe (as above) cold
speciﬁc competitor (tracks 3 and 4) or 5′ LRE RNA probe (tracks 5 and 6). Experiments
were performed in duplicate and shown electrophoresed on the same gel.
Fig. 4. HuR regulates expression of L1 protein in W12 cells (A) Northern blot of mRNA isolated from W12 cells transiently transfected with (1) vector control, pcDNA3.1 and (2) HuR
expressing plasmid, pcDNA3HuR and probed with [32P]-labelled, random primed insert from pHPV16-RL1 containing sequences 6151 to 6819 of the L1 coding region of the HPV16
genome. The blots were stripped and reprobed with an actin probe. (B)Western blots of total protein lysates fromW12 cells transfected as abovewith (1) pcDNA3.1 and (2) pcDNA3HuR
and probedwith L1 antibody, HuR antibody 19F12 to show endogenous levels of HuR (1) and successful transfectionwith pcDNA3HuR (2) and GAPDH antibody to show similar levels of
protein lysates fractionated in each track. UW12, undifferentiatedW12 cell extracts; DW12, differentiatedW12 cell extracts. (C) Quantiﬁcation of data from three separate experiments to
show a 5-fold increase in L1 protein levels (relative to levels of GAPDH as a loading control) upon transfection of the HuR expression construct. (D) Semiquantitative RT-PCR showing
relative levels of GADPH and L1mRNAs in cells expressing HuR siRNA.1. Control scrambled siRNA, no reverse transcriptase. 2. Control scrambled siRNA,with reverse transcriptase. 3. HuR
siRNA, no reverse transcriptase. 4.HuR siRNA,with reverse transcriptase. (E)Westernblots of total protein lysates fromW12cells transfectedwith control scrambled siRNAandHuR siRNA.
Antibodies were used as in (B). (F) Quantiﬁcation of a representative experiment (three separate experiments were carried out) showing an approximate 2-fold reduction in L1 protein
levels in response to a 50% reduction in levels of endogenous HuR. A similar amount of protein was electrophoresed in each track in the western blots in B and D but different exposure
times are shown.
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al., 2007) and this was also the case when the cells were transfected
with HuR siRNAs (data not shown).
Discussion
Papillomavirus late gene expression is controlled post-transcrip-
tionally (Graham, 2006). Although the capsid proteins are expressed
exclusively in granular layer cells of infected epithelia, RNAs encoding
these proteins can be detected in less differentiated cells (Beyer-Finkler
et al., 1990; Stoler et al., 1989). Previous data has indicated that HPV16
late gene expressionmay be regulated via the LRE present in the late 3′
UTR at the level of mRNA stability (Kennedy et al., 1991; Tan et al.,
1995). Tan et al. (1995) showed that in HeLa cells transfected with a
retrovirus-based expression vector containing the HPV16 L1 gene, but
including only the ﬁrst 25 nucleotides of the LRE, L1 mRNAs were
present in the cytoplasm but L1 protein was not made. This suggested
that L1 mRNAs were unable to be translated either because they were
unstable or because they were unable to reach the polysomes.
However, the expression vector also contained the 5′ end of the HIV-
1 genome, including the LTR so these HIV-speciﬁc signal sequences
that are known to have post-transcriptional effects may have
contributed to the regulation observed. Kennedy et al., (1991)
demonstrated that in vitro transcribed 445 nt RNAs containing the
LRE and the HPV16 late 3′ UTR were very unstable in a HeLa in vitro
decay assay. In contrast, a 227 nt RNA at the 3′ end of the 445 nt
fragment, that does not contain the LRE, was considerablymore stable.
More recently, we demonstrated that although HPV16 late transcripts
are readily detected in total RNA from both undifferentiated anddifferentiated W12 cells, polyadenylated mRNA is detected only in
differentiated W12 cells (Milligan et al., 2007). Previous studies
indicated that these RNAs were conﬁned to the nucleus (Koffa et al.,
2000). This suggests that although late genes are transcribed in
infected undifferentiated epithelial cells, these RNAs are not poly-
adenylated and are unstable.
HuR binds to AU-rich elements (AREs) in the 3′ UTR of mRNAs that
are unstable. There are three classes of AREs. Class I contain the
classical pentamer AUUUA, class II have a nonamer UUAUUUA(U/A)(U/
A) and class III lack an AUUUA motif but are U-rich. Overexpression of
HuR appears to stabilise such RNAs by inhibiting their degradation.
For example, human vascular endothelial growth factor (VEGF) has a
class III ARE in its 3′ UTR that binds HuR with high afﬁnity. In hypoxia,
HuR overexpression efﬁciently stabilises VEGF mRNA (Levy et al.,
1998). In addition to a role in controlling RNA stability, HuR can
regulate alternative splicing (Zhu et al., 2006) and translation (Kawai
et al., 2006). HuR is a nucleo-cytoplasmic shuttling protein and
evidence suggests that it binds target RNAs in the nucleus,
accompanies them to the cytoplasm and promotes their stability on
polysomes (Fan and Steitz,1998; Peng et al.,1998). Using EMSA and UV
crosslinking studies we have demonstrated binding of HuR to the
HPV16 LRE in W12 cell extracts in a differentiation stage-speciﬁc
manner. UV crosslinking studies showed that HuR is one of the main
proteins that can interact with LRE RNA (data not shown). In EMSA,
puriﬁed GST–HuR binds with high afﬁnity to the LRE and analysis of
LRE deletion mutants revealed that binding was predominantly to the
U-rich 3′ portion. The 3′ portion is 30 nts in length, 12 nts longer than
amodel minimum high afﬁnity binding site for HuR (Fialcowitz-White
et al., 2007). Site-directedmutagenesis did not reveal a shorter portion
147S.A. Cumming et al. / Virology 383 (2009) 142–149that was capable of binding HuR efﬁciently. Multimerisation of HuR
upon the entire LRE was observed and to a lesser extent upon its 3′
portion (Figs. 3A and B). The 3′ LRE resembles a class III ARE as there
are no AUUUA motifs in the element. These results contribute to the
list of RNA sequences to which HuR can bind.
EMSA revealed that in in vitro cell extracts HuR can bind the LRE in
the cytoplasm of undifferentiated W12 cells but binds particularly
efﬁciently in both the nucleus and cytoplasm of differentiated W12
cells. The RNA/protein complex detected with cytoplasmic extracts of
differentiated W12 cells appears to comprise largely HuR as it is
severely depleted upon inclusion of 16A5 anti-HuR antibody (this
antibody does not cause a supershift) in the EMSA reaction mix. We
suggest that in differentiated epithelial cells HuR is necessary for
export and stability of LRE-containing mRNAs to the cytoplasm. In
undifferentiated epithelial cells LRE-containing late mRNAs do not
reach the cytoplasm (Koffa et al., 2000) and are unstable (Milligan et
al., 2007) perhaps because HuR is not available for LRE binding as the
element binds a splicing-related complex (Cumming et al., 2003).
Alternatively, nuclear HuR may be sequestered in these cells by
binding to other proteins or RNAs. When differentiation takes place
the afﬁnity of the splicing-like complex for the LRE may decrease
perhaps due to phosphorylation of the SF2/ASF component (McPhil-
lips et al., 2004) or due to increased availability of HuR to the LRE. The
LRE-containing mRNAs begin to be efﬁciently polyadenylated and
exported to the cytoplasm accompanied by HuR in a stabilising
complex, perhaps in partnership with other proteins. One such protein
might be hnRNP A1 that we have shown binds the central portion of
the LRE in W12 cells and whose levels are increased in differentiated
epithelial cells (Chuen-Im et al., 2008). hnRNP A1 could help stabilise
the late transcripts leading to efﬁcient translation.
The hypothesis that HuR is involved in regulating HPV16 late gene
expression was tested by overexpressing the protein in undifferen-
tiated and differentiatedW12 cells and assaying expression of the late
mRNAs and L1 protein. Differentiation was by the methylcellulose
method that allows rapid differentiation of transfected W12 cells
during the expected time course (up to 48 h) of expression of the
transiently transfected vector. There was no obvious effect on
expression of late mRNAs and L1 protein in differentiated W12 cells.
It is possible that overexpression has little effect on the nuclear and
cytoplasmic pools of HuR available to LRE-containing late RNAs in
these cells. In contrast in undifferentiated cells increased levels of HuR
resulted in a clear increase in L1 mRNA expression mirrored by the
appearance of detectable levels of L1 protein. Increasing levels of HuR
in undifferentiated W12 cells may tip the balance of what protein
complexes can bind the LRE allowing access of HuR to the LRE on at
least some late transcripts in competition with the splicing-related
complex that usually binds. This could result in alleviation of the
proposed splice complex inhibition of polyadenylation (Graham,
2008) leading to stabilisation of LRE-containing mRNAs and efﬁcient
translation in the cytoplasm. In contrast, siRNA knock down of HuR in
differentiated W12 cells depleted levels of L1 mRNA and protein. This
lends support to the hypothesis that HuR is a positive regulator of L1
expression during differentiation of HPV16-infected epithelia.
CUGBP1 has recently been shown also to bind the 3′ LRE and is
proposed to synergise with U1 snRNP bound to the 5′ portion.
However, functional analysis of CUGBP1 has only been performed in
HeLa cells thus far (Goraczniak and Gunderson, 2008). Our present
study reports the ﬁrst in vivo functional study of an HPV16 LRE-
binding protein in a good model system for the virus life cycle.
HuR appears to be a major regulator of HPV16 late gene expression
during differentiation of infected epithelial cells andmay contribute to
repression of capsid protein expression in undifferentiated epithelial
cells. Our data may also suggest that HuR acts as a positive regulator of
capsid protein production in differentiated epithelial cells. Discovery
of such cellular factors that control late protein production may open
the way for design of novel antiviral therapies. Small moleculeinhibitors of HuR have recently been identiﬁed (Meisner et al., 2007)
that may prove therapeutically useful in future.
Materials and methods
Cell culture
20863 (W12E) (Jeon et al., 1995) is a subclone of the W12 cell line
(Stanley et al., 1989) and contains 50–100 episomal copies of the
HPV16 genome. For monolayer culture, W12E cells were co-cultured
withmitomycin C-treated J2 3T3 ﬁbroblast feeder cells at a ratio of 1:5,
seeding W12E cells at 2×105 cells/100 mm dish (Jeon et al., 1995). The
W12E line was grown without passaging for up to 5 days for
undifferentiated cells, and 10 days for differentiated cells (McPhillips
et al., 2004) (Milligan et al., 2007). HeLa cells were cultured in DMEM
supplemented with 10% foetal bovine serum and 2 mM L-glutamine
(Invitrogen). All cells were grown at 37 °C in 5% CO2.
Transient transfection
Undifferentiated W12 cells were grown at low density in F-
medium in the presence of J2 3T3 cell feeder layers. After 4 days 3T3
cells were removed by trypsinisation and W12 cells were transfected
with pcDNA3.1 or pcDNA3HuR using Lipofectamine 2000 (Invitrogen)
at 0.5 μg DNA per 2×105 cells per 35 mm well. 16 h after transfection
cells were differentiated for 48 h in methylcellulose (Ruesch et al.,
1998). For siRNA knock-down HuR siRNA pools or scrambled control
siRNA pools (0.5 μg each siRNA pool (Santa Cruz)) were transfected
using the siRNA transfection reagent provided into 2×105W12 cells in
35mmwells and cells were differentiated in methylcellulose as above.
Total cell, nuclear and cytoplasmic protein extraction
Prior to preparation of W12 extracts feeder, cells were removed by
treatment with 0.1% trypsin–0.5 mM EDTA. For total cell extracts, cells
were washed twice in PBS and lysed directly in 2×protein loading
buffer [63 mM Tris–HCl, pH 6.8, 1% (wt/vol) SDS, 10% glycerol, 5% (vol/
vol) β-mercaptoethanol, 0.004% (wt/vol) bromophenol blue] followed
by sonication until viscosity was decreased. Nuclear and cytoplasmic
extracts were prepared as described (Dignam et al., 1983).
Western blotting
Proteins were separated on 12% SDS-PAGE before electroblotting
onto polyvinylidene ﬂuoride (PVDF) membranes (Amersham). The
membranes were blocked in 5% (w/v) dried milk powder in
phosphate-buffered saline (PBS) overnight at 4 °C. Primary antibodies
were diluted in PBS with 5% (w/v) dried milk powder, 0.05% (v/v)
Tween-20 (PBS-T) and incubated with the membranes for 1 h at room
temperature with shaking. The anti-HuR antibodies 19F12 (Santa
Cruz) and 16A5 (gift fromHenry Furneaux; Levy et al., 1998) were used
at a dilution of 1/500, antibody MC3 against U2AF65 (gift from M.
Carmo-Fonseca) was used at a dilution of 1/100, monoclonal
antibodies against involucrin (SY5; Sigma) and GAPDH (6CS; Biode-
sign International) were used at a dilution of 1/1000. L1 antibody
(Pharmingen) was used at a dilution of 1/250. After washing with PBS-
T, the membranes were incubated with an anti-mouse secondary
antibody-horseradish peroxidase (Sigma) at a dilution of 1/1000 for
1 h at room temperature. Following washing in PBS-T, antibody–
protein complexes were visualised using ECL reagents (Amersham)
according to the manufacturer's instructions.
Electrophoretic mobility shift assay (EMSA) and UV crosslinking
Primer sequences used to generate riboprobe templates by PCR
ampliﬁcation of pCATPE445 were as described (Cumming et al., 2003).
148 S.A. Cumming et al. / Virology 383 (2009) 142–149PCR products were puriﬁed on 6% polyacrylamide gels. Riboprobes
were synthesised with the Stratagene RNA in vitro transcription kit
with addition of 25 μCi [α-32P]UTP (800 mCi/mmol; NEN) following
the manufacturer's protocol and puriﬁed from 5% denaturing poly-
acrylamide gels. EMSAs were carried out as described (Cumming and
Graham, 2005). Speciﬁc competitor RNA was in vitro transcribed with
the addition of unlabelled UTP substituting for [α-32P] UTP. Non-
speciﬁc competitor RNA (65 nts) was transcribed from pBluescript KS
(+) (Stratagene) polylinker linearised with EcoRI. Supershift EMSA
experiments were carried out by preincubation of nuclear or
cytoplasmic extracts with 1 μg HuR antibody 19F12 for 15 min on ice.
Depletion reactions were carried out by preincubating extracts with
1 μg 16A5 HuR antibody for 15min on ice before addition of the probe.
The EMSA reactionswere electrophoresed on a 5% non-denaturing gel.
UV crosslinking was carried out as described (Cumming and Graham,
2005) using a Stratalinker (Stratagene) at a setting of 250 mJ. For
competition experiments, cold probe was added prior to addition of
50 ng GST–HuR. Reactions were carried out at room temperature for
15 min. followed by RNase A digestion (20 μg per reaction) at 37 °C for
30 min. Labelled proteins were fractionated on 12% SDS-PAGE.
GST–HuR puriﬁcation
GST-tagged HuR expression plasmid (pGEX-HuR; gift from Joan
Steitz, Yale University, New Haven, USA) was transformed into BL-21
cells. Logarithmic phase cells were induced with 1 mM IPTG at 37 °C
for 3 h, then pelleted. The pellet was resuspended in 1 ml lysozyme
(10 mg/ml) in PBS and incubated on ice for 15 min before incubating
with 100 μl Triton X-100 for another 15 min. The supernatant was
collected by centrifugation at 9500 rpm and mixed with 1 ml of 50%
glutathione sepharose (Amersham) for 1 h at 4 °C beforewashingwith
PBS. The protein was eluted in 5 mM reduced glutathione in 50 mM
Tris pH 8.0 three times and the concentration of puriﬁed HuR was
determined by Bradford assay.
RNA preparation and Northern blotting
For preparation of RNA fromW12 cells 3T3 feeder layer cells were
removed by trypsinisation. W12 cells were washed with PBS then
scraped into Trizol reagent (Invitrogen) and total RNA was prepared
according to the manufacturer's instructions. Polyadenylated RNAwas
selected by hybridisation to oligo(dT) cellulose using an Oligotex
mRNA puriﬁcation kit (Qiagen) according to the manufacturer's
instructions. 0.5 μg polyadenylated RNA per track was fractionated
on a 1.2% agarose, 2.2M formaldehyde gel in MOPS buffer and
transferred to Hybond-N (Amersham) as described (Sambrook et al.,
1989). Blots were hybridised in 5xSSC, 50% formamide at 42 °C
overnight and washed to 0.1×SSC at 65 °C. Blots were dried and
exposed to X-ray ﬁlm overnight, or longer. Reverse transcriptase PCR
(RT-PCR) was carried out using an Invitrogen First Strand Superscript
III cDNA synthesis kit according to the manufacturer's instructions
followed by simultaneous PCR ampliﬁcation of L1 and GAPDH cDNAs
using L1 Forward primer (5′CCTACACCTAGTGGTTCTATGGTTACC3′)
and L1 Reverse primer (5′GGAAACTGATCTAGGTCTGCAG3′) with
GAPDH Forward primer (5′TCCACCACCCTGTTGCTGTA3′) and GAPDH
Reverse primer (5′ACCACAGTCCATGCCATCAC3′) and Taq polymerase
(Invitrogen). 35 cycles were performed of 94 °C for 15 s. 55 °C for 30 s
and 72 °C for 1 min.
Immunohistochemistry of raft tissue
Organotypic raft cultures were performed exactly as described
(Meyers and Laimins, 1994). Following growth at the liquid/air
interface for 14 days, raft tissues were ﬁxed in 10% neutral buffered
formalin overnight and parafﬁn-embedded. 4 μm sections were cut
and ﬁxed on poly-L-lysine (sigma)-coated slides. Immunocytochem-istry was performed using the ABC Elite Kit (Vector laboratories)
according to the manufacturer's instructions. For antigen retrieval, the
tissue was heated in citrate buffer at pH 6.0 for 10 min in a microwave.
Sections were blocked in PBS-20% foetal calf serum for 1 h before
incubating with primary antibody for 1 h at 4 °C. Monoclonal
antibodies MC3 against U2AF65 and 16A5 against HuR were used at
concentrations of 1/10 and 1/5 respectively. Diaminobenzidine
tetrahydrochloride (DAB) (Vector Laboratories was used as the
chromogen and tissues were counterstained with hematoxylin.
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